Mirum Pharmaceuticals (MIRM) Retained Earnings (2018 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Retained Earnings of -$1.5 billion for Q1 2026, down 581295.35% year-over-year from N/an in Q1 2025, and down 124.7% quarter-over-quarter from -$667.5 million in Q4 2025.
Mirum Pharmaceuticals (MIRM) Retained Earnings (2018 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Retained Earnings history runs 9 years deep, the most recent figure standing at -$1.5 billion for Q1 2026.
- In Q1 2026, Retained Earnings fell 581295.35% year-over-year to -$1.5 billion; the TTM figure through Mar 2026 stood at -$1.5 billion (down 581295.35% YoY), while the FY2025 annual figure was -$667.5 million, down 3.63% from the prior year.
- Retained Earnings for Q1 2026 stood at -$1.5 billion, down from -$667.5 million in the prior quarter.
- The five-year high for Retained Earnings was $920000.0 in Q3 2024, with the low at -$1.5 billion in Q1 2026.
- The 5-year median for Retained Earnings is -$423.0 million (2023), against an average of -$403.2 million.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings slumped 1122254.29% in 2022, then soared 163.1% in 2024.
- Mirum Pharmaceuticals' Retained Earnings stood at -$392.8 million in 2022, then tumbled by 41.6% to -$556.2 million in 2023, then slipped by 15.81% to -$644.2 million in 2024, then decreased by 3.63% to -$667.5 million in 2025, then plunged by 124.7% to -$1.5 billion in 2026.
- Business Quant data shows MIRM's Retained Earnings at -$1.5 billion in Q1 2026, -$667.5 million in Q4 2025, and $37000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | -1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.52 Bn |
| Mar 31, 2026 | -1.50 Bn |
| Dec 31, 2025 | -667.54 Mn |
| Sep 30, 2025 | 37,000.00 |
| Jun 30, 2025 | -664.70 Mn |
| Mar 31, 2025 | -258,000.00 |
| Dec 31, 2024 | -644.18 Mn |
| Sep 30, 2024 | 920,000.00 |
| Jun 30, 2024 | -606.16 Mn |
| Mar 31, 2024 | -581.50 Mn |
| Dec 31, 2023 | -556.24 Mn |
| Sep 30, 2023 | -1.46 Mn |
| Jun 30, 2023 | -496.99 Mn |
| Mar 31, 2023 | -422.95 Mn |
| Dec 31, 2022 | -392.82 Mn |
| Sep 30, 2022 | -413,000.00 |
| Jun 30, 2022 | -320.70 Mn |
| Mar 31, 2022 | -131,000.00 |
| Dec 31, 2021 | -35,000.00 |
| Sep 30, 2021 | -6,000.00 |